Inside the European mass shift to data-driven health solutions
Sectors
NICE questions value and efficacy of five Covid-19 drugs with rejection
This week, NICE rejected five major Covid-19 therapies due to high costs and uncertainties in clinical evidence.
Drug developers look at innovative mechanisms to tackle dry eye syndrome
How environmental factors could influence disease and drugs
CMO Moves: Regulatory catalysts for drug manufacturing-September
Rare Disease Spotlight- Oncology therapies dominate the orphan drug landscape
Top tweets: Paxlovid Rx in Covid-19 treatment – and more
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
